Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Rite Aid February Same-Store Sales Rose 3.1%; Up 3% In 4Q

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:07pm CEST

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.1% in February, marking the 11th straight month of growth for the drug store chain.

The No. 3 U.S. drug store chain behind Walgreen Co. (>> Walgreen Company) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month last year -- March had a 0.1% drop -- with a boost from the rollout of a loyalty program and store renovations that expanded clinical pharmacy services and health and wellness products choices.

During February, same-store sales were up 1.9% in the front of the store. Pharmacy same-store sales increased 3.7%, despite a negative impact of 2.42 percentage points from generic drug introductions. Same-store prescription counts were up 2.2%.

For the fiscal fourth quarter ended March 3, same-store sales improved 3%, including growth of 1.6% in the front of the store and 3.8% in the pharmacy section.

Total February drug store sales rose 2.3% to $2.55 billion. Prescription sales accounted for 68.3% of drugstore sales.

For the quarter, total drug store sales rose 2.5% to $7.12 billion.

Rite-Aid, which has about 4,667 stores, has posted losses since its 2007 acquisition of the Brooks Eckerd Pharmacy chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed as same-store sales grew for a fourth consecutive quarter and interest expense and lease termination and write-down charges declined.

Shares were up 1.2% at $1.71 in recent premarket trading. Through Wednesday's close, the stock is up by slightly more than a third this year.

 
   -By Tess Stynes, Dow Jones Newswires; 212-416-2481; [email protected] 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
09/22 INTERRA RESOURCES : Walgreens-Rite Aid deal gets regulatory green light
09/22 LAW AND ORDER : Albion woman accused of stealing oral hygiene products from Rite..
09/21 LAW AND ORDER : Man accused of stealing cologne from Rite Aid arrested
09/20 Biz quicks
09/20 RITE AID, WALGREENS DEAL : What's happening, what does it mean, what's next?
09/20 FTC Commissioner McSweeny Comments on Walgreens/Rite Aid Transaction
09/20 INTERRA RESOURCES : FTC Acting Chairman Ohlhausen Comments on Walgreens/Rite Aid..
09/20 Walgreens, Rite Aid trim their deal; Business briefing; Homebuilding drops in..
09/20 INTERRA RESOURCES : Following Attorney General Schneiderman Investigation, Walgr..
09/20 Walgreens, Rite Aid trim purchase deal to $4.38B
More news
News from SeekingAlpha
09:49a Stocks to Watch Next Week
09/22 RITE AID'S REVISED DEAL : What Now?
09/19 WALGREENS BOOTS ALLIANCE : How The $4 Billion Rite Aid Deal Improves This Divide..
09/19 Midday Gainers / Losers
09/19 PREMARKET LOSERS AS OF 9 : 05 am
Financials ($)
Sales 2018 31 088 M
EBIT 2018 285 M
Net income 2018 -142 M
Debt 2018 6 795 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 0,30x
Capi. / Sales 2019 0,08x
Capitalization 2 517 M
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 2,45 $
Spread / Average Target 2,5%
EPS Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Bryan B. Everett Chief Operating Officer-Rite Aid Stores
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-70.63%2 517
RAIA DROGASIL SA26.04%7 903
AIN HOLDINGS INC1.29%2 448
PALTAC CORP53.22%2 403
ORIOLA OYJ-20.88%761
PETMED EXPRESS INC55.40%728